Structure Info
- Chemspace ID
- CSCS14948331257 (Synthesis)
- IUPAC Name
- 2-(7-{4-[(3Z)-5-bromo-3-[(3-bromo-4-hydroxy-5-methoxyphenyl)methylidene]-2-oxo-2,3-dihydro-1H-indol-1-yl]butoxy}-6-methoxy-1-methyl-1,2,3,4-tetrahydroisoquinolin-1-yl)-N-(1,3-thiazol-2-yl)acetamide
- Mol formula
- C36H36Br2N4O6S
- Mol weight
- 813 Da
- Catalog Number(s)
- HY-163141
- Copy structure to query editor
- SMILES
- INCHI
- INCHI key
- MOL
Properties
- LogP
- 5.72
- Heavy atoms count
- 49
- Rotatable bond count
- 12
- Number of rings
- 6
- Carbon bond saturation, Fsp3
- 0.305
- Polar surface area (Å)
- 122
- Hydrogen bond acceptors count
- 8
- Hydrogen bond donors count
- 3
- Zoom the structure
- CSCS14948331257
Items Overall 2 items from 2 suppliers
| Supplier | Lead time | Ships from | Purity | Pack | Price, $ | Qty |
|---|---|---|---|---|---|---|
| MedChemExpress | TBD | United States To: | 90 | 1 mg | POA | |
Description: Names: PCSK9-IN-24; Product Description: PCSK9-IN-24 (Compound OY3) is a compound that targets PCSK9 . PCSK9-IN-24 reduces PCSK9 levels and increases LDL uptake and may be used in atherosclerosis research .; Target: PCSK9; CAS: 2974496-96-1 | ||||||
| MedChemExpress EU | TBD | Sweden To: | 90 | 1 mg | POA | |
Description: Names: PCSK9-IN-24; Product Description: PCSK9-IN-24 (Compound OY3) is a compound that targets PCSK9. PCSK9-IN-24 reduces PCSK9 levels and increases LDL uptake and may be used in atherosclerosis research; Target: PCSK9; CAS: 2974496-96-1 | ||||||
For a custom pack size or bulk
please drop us a line:Enquire
please drop us a line:Enquire